IP Library Granted Patent US 7,129,038
Granted Patent B2
US 7,129,038 · App. 10/177,542 · Granted Oct 31, 2006

Method for selectively combining multiple membranes for assembly into test strips

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,129,038
App. No.
10/177,542
Granted
Oct 31, 2006
Kind
B2
Abstract

A method for selectively combining multiple membranes for assembly into test strips (such as visual blood glucose test strips with side-by-side membranes). The method includes first measuring a plurality of color parameters (e.g., L*, a* and b*color parameters) associated with membrane samples from at least two membrane lots. Next, response characteristics (e.g., blood glucose response levels) are simulated for a speculative test strip that includes, for purposes of the simulation, combined multiple membranes tentatively selected from the at least two membrane lots. The simulated response characteristics are based on the measured plurality of color parameters of the tentative selection of combined multiple membranes. Optionally, the simulated response characteristics can also be based on simulated color parameters of the tentative selection of combined multiple membranes. Subsequently, assembly of the at least two membrane lots into a test strip with combined membranes is contingent on acceptable simulated response characteristics. Any suitable color parameters can be employed. The method can be used to selectively combine two or more membranes based on any number of color parameters. The assembled test strips can be used to measure glucose, cholesterol, proteins, ketones, phenylalanine or enzymes in blood, urine, saliva or other biological fluid, as well as sample fluid characteristics (e.g., pH and alkalinity).

Claims (41)

1. A method for selectively combining multiple membranes for assembly into test strips comprising:

measuring a plurality of color parameters associated with membrane samples from at least a first lot of membranes and a second lot of membranes;

simulating response characteristics of a speculative test strip that includes, for purposes of simulating the response characteristics, combined multiple membranes tentatively selected from the at least first lot of membranes and second lot of membranes, the simulated response characteristics being based on the measured plurality of color parameters of the tentative selection of combined multiple membranes,

wherein the simulated response characteristics are also based on simulated color response data and are obtained utilizing an experimentally-derived multivariate mixed model equation of the form:

R=Yβ+Zγ+e

 where:

R is an N×1 vector of color parameter responses;

β is a b×1 vector of fixed effect coefficients;

Y is an N×b matrix of independent covariates;

γ is a g×1 vector of random effect coefficients;

Z is an N×g matrix of random effects; and

e is a N×l vector of residual errors; and

assembling the at least first and second lot of membranes from which the combined multiple membranes were tentatively selected into a test strip with combined membranes, the assembly contingent on an assessment of acceptable test strip clinical accuracy based on the simulated response characteristics.

2. The method of claim 1 , wherein the simulating step further includes estimating the variances of the simulated response characteristics and adjusting the variances for user-related visual effects.

3. The method of claim 1 , wherein the assembling step includes assembly contingent on an assessment of acceptable test strip clinical accuracy based on the simulated response characteristics as determined by comparison of the simulated response characteristics to a specification indicative of test strip of acceptable clinical accuracy.

4. The method of claim 1 , wherein the assembling step includes assembly contingent on an assessment of acceptable test strip clinical accuracy based on the simulated response characteristics as determined using a Clarke's Error Grid analysis.

5. The method of claim 1 , wherein the measuring step measures L*, a* and b*color parameters of the L*a*b*color space of the Commission Internationale de L'Eclairage.

6. The method of claim 1 , wherein the measuring step is accomplished using a chromameter.

7. The method of claim 1 , wherein the measuring step is accomplished using a spectrophotometer.

8. The method of claim 1 , wherein the measuring step measures X, Y and Z color parameters of the XYZ tristimulus space.

9. The method of claim 1 , wherein the measuring step measures Y, x and y values of the Yxy color space.

10. The method of claim 1 , wherein the measuring step measures L, C and h values of the L*C*h color space Commission Internationale de L'Eclairage.

11. The method of claim 1 , wherein the measuring step measures HL, a and b values of the Hunter Lab color system.

12. The method of claim 1 , wherein the measuring step includes measuring a plurality of color parameters on membrane samples that have been reacted with an analyte.

13. A method for selectively combining multiple membranes for assembly into visual test strips, the visual test strips for use in determination of analyte concentration in a biological fluid, the method comprising:

measuring L*, a* and b*color parameters, Commission of the Internationale de L'Eclairage, associated with membrane samples from at least a first lot of membranes and a second lot of membranes;

obtaining simulated color parameters associated with the membrane samples selected from at least the first lot of membranes and the second lot of membranes;

simulating response characteristics of a speculative test strip that includes, for purposes of simulating the response characteristics, combined multiple membranes tentatively selected from the at least first lot of membranes and second lot of membranes, the simulated response characteristics being based on the measured plurality of color parameters and the simulated color parameters of the tentative selection of combined multiple membranes,

wherein the simulated response characteristics are also based on simulated color response data and are obtained utilizing an experimentally-derived multivariate mixed model equation of the form:

R=Yβ+Zγ+e

 where:

R is an N×1 vector of color parameter responses;

β is a b×1 vector of fixed effect coefficients;

Y is an N×b matrix of independent covariates;

γ is a g×1 vector of random effect coefficients;

Z is an N×g matrix of random effects; and

e is a N×l vector of residual errors; and

assembling the at least first and second lot of membranes into a test strip with combined membranes contingent on an assessment of acceptable test strip clinical accuracy based on the simulated response characteristics.

14. The method of claim 13 , wherein the simulating step further includes estimating the variances of the simulated response characteristics and adjusting the variances for user-related visual effects.

15. The method of claim 13 , wherein the assembling step includes assembly contingent on an assessment of acceptable test strip clinical accuracy based on the simulated response characteristics as determined by comparison of the simulated response characteristics to a specification indicative of a test strip of acceptable clinical accuracy.

16. The method of claim 13 , wherein the assembling step includes assembly contingent on an assessment of acceptable test strip clinical accuracy based on the simulated response characteristics as determined using a Clarke's Error Grid analysis.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →